Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1991-11-27
1993-06-22
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514923, A61K 3155
Patent
active
052216721
ABSTRACT:
The compound t-butyl (S)-8-bromo-11,12,13,13a-tetrahydro-9-oxo-9H-imidazo[1,5-a]pyrrolo[2,1-c][ 1,4]benzodiazepine-1-carboxylate of the formula ##STR1## can be used for the preparation of medicaments for the treatment of sleep disorders and also as a medicament for the treatment of sleep disorders.
REFERENCES:
patent: 4352815 (1982-10-01), Hunkeler et al.
patent: 4353827 (1982-10-01), Hunkeler et al.
patent: 4861772 (1989-08-01), Merz
patent: 4914095 (1990-04-01), Merz
Saletu, et al., Int. J. Clin. Pharmacol. Ther. and Toxicol., vol. 27, No. 2 (1989).
Belzung, et al., Psychopharmacolog, vol. 97, 338-391 (1989).
Schreur, et al., Society for Neuroscience Abstracts, vol. 15, No. 2, (1989).
Pieri, et al., Drugs of the Future, vol. 13, No. 8 730-735 (1988).
Berkow, et al., The Merck Manual, 1376-1377 (1987).
Amrein Roman
Laurent Jean-Paul
Gould George M.
Hoffmann-La Roche Inc.
Johnston George W.
Krovatin William
Waddell Frederick E.
LandOfFree
Pharmaceutical compositions containing bretazenil and methods of does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compositions containing bretazenil and methods of, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions containing bretazenil and methods of will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1441150